$1000 Invested In Halozyme Therapeutics 15 Years Ago Would Be Worth This Much Today

Halozyme Therapeutics (NASDAQ:HALO) has outperformed the market over the past 15 years by 8.16% on an annualized basis producing an average annual return of 21.6%. Currently, Halozyme Therapeutics has a market capitalization of $13.13 billion.

Buying $1000 In HALO: If an investor had bought $1000 of HALO stock 15 years ago, it would be worth $19,014.83 today based on a price of $115.65 for HALO at the time of writing.

Halozyme Therapeutics’s Performance Over Last 15 Years

Finally -- what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga's automated content engine and reviewed by an editor.